Navigation Links
Medivation to Present at 8th Annual Needham Life Sciences Conference
Date:6/4/2009

SAN FRANCISCO, June 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that David Hung, M.D., president and chief executive officer, will present at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, at 10:30 a.m. Eastern Time at the New York Palace Hotel.

Dr. Hung will provide an overview of Medivation and its clinical development programs for Dimebon for Alzheimer's and Huntington's diseases and MDV3100 for prostate cancer.

A live audio webcast of the corporate presentation will be available on the "Events and Presentations" page of the "Investor Relations" section of the Company's website at http://www.medivation.com. A replay also will be available for 30 days following the live presentation.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program that includes several Phase 3 trials assessing the efficacy and safety of Dimebon taken alone or in combination with other Alzheimer's medication in patients with mild, moderate or severe Alzheimer's disease. Further development of Dimebon in patients with Huntington's disease is also planned. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castrati
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medivation Announces Offering of 2,750,000 Shares of Common Stock
2. Medivation Announces Upcoming Presentation of New MDV3100 Data in Patients With Advanced Prostate Cancer at 45th American Society of Clinical Oncology Annual Meeting
3. Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference
4. Medivation Reports First Quarter 2009 Financial Results and Provides Corporate Update
5. Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
6. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
7. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
8. Medivation Announces Participation in Upcoming Conferences
9. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
10. Medivation Announces Participation in Upcoming Conferences
11. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... PA (PRWEB) , ... July 31, 2015 , ... M3 ... is excited to launch three new Board Exam Courses. , The additions of ... Doc Board Exam Prep from MDLinx makes preparing for the exam easy and painless. ...
(Date:7/31/2015)... CA (PRWEB) , ... July 31, 2015 , ... According ... and cosmetic experts gathered to see if they could reach a consensus on the ... breast augmentation and facelifts. Overall, the group reached 90 percent consensus on a series ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and potential patients alike on various plastic surgery procedures including, but not limited ... such popular dermatology procedures like Botox and fillers. , Staying up to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based ... sales were up 16 percent year-over-year for the first six months ended June 30, ... he expected Transfinder to beat last year’s record-revenue mark of $10.4 million. , “We ...
(Date:7/31/2015)... ... , ... Girl Scouts of Historic Georgia and Peach State Health Plan are ... a Friend First" program. Representatives from Peach State Health Plan presented a $10,000 check ... and our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We are ...
Breaking Medicine News(10 mins):Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... to be Opened in the North West of England -, ... ORCH ), a leading worldwide provider of identity DNA testing,services, ... in the North West of England later this year following ... work was awarded to Orchid,Cellmark following the North West/South West ...
... April 21 MedCath Corporation,(Nasdaq: MDTH ) announced ... 2008, which ended March 31, 2008. In addition, MedCath,announced ... second quarter of fiscal 2008 and its revised outlook ... asset held for sale. MedCath,announced on March 24, 2008 ...
... HILL, N.C., April 21 Marketing brand leaders ... services offered by,Best Practices, LLC and in particular ... the Best Practice Database (, http://www.BestPracticeDatabase.com ). ... downloaded individually, many commercial leaders have come to,find ...
... planting low-allergen species, avoiding high pollen hours can help ... with allergies, it can be difficult to enjoy their ... the misery of sneezing, itchy eyes, congestion and, in ... times of high pollen counts puts patients at risk ...
... Association (PCMA) issued the following statement today,regarding a story ... "The New York Times has missed another opportunity to ... In the April 14,2008 piece, ,Co-payments Soar for Drugs ... for the high cost of biotech treatments. Then,in a ...
... The American Academy of,Pediatrics (AAP) highlights the ... Immunization Week, April 19-26. Vaccines,have eliminated or reduced ... a critical component of the nation,s public health ... Disease Control and Prevention,before immunization:, -- Over ...
Cached Medicine News:Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 2Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 3Health News:Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services 4Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 2Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 3Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 4Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 5Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 6Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 7Health News:Best Practice Database Provides Exceptional Value to Marketing Executives 2Health News:Allergies Can Dig Into Gardening's Fun 2Health News:PCMA Response to New York Times Article on Biotech Medicine Costs 2Health News:AAP Encourages Parents to Immunize Their Children 2
(Date:7/31/2015)... 2015 Magnaquest, a leading ... and cloud computing operators has signed a Proof ... for Internet of Things (IoT) related initiative. The ... subscription model.      (Logo: http://photos.prnewswire.com/prnh/20140807/700645 ... for business innovations to make healthcare services more ...
(Date:7/30/2015)... 2015  ResMed (NYSE: RMD ) ... agreement to acquire Curative Medical, a privately-held ... breathing medical devices and accessories. ... leadership in sleep and respiratory medicine, will ... suffering from sleep-disordered breathing and ...
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
Breaking Medicine Technology:Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... ALBUQUERQUE, N.M., Jan. 25, 2011 Exagen Diagnostics, ... and markets proprietary tests, announced today the completion of ... New Mexico Science and Technology Park . The expansion, ... laboratory, allows Exagen to accommodate growing test volume for ...
... Mass., Jan. 25, 2011 Generex Biotechnology Corporation ( ... together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, ... amended the Clinical Study Agreement with The Henry M. ... ( www.hjf.org ) in regard to the on-going Phase ...
Cached Medicine Technology:Exagen's Corporate Expansion Creates Job Opportunities in New Mexico 2Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 2Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 3Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 4Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 5
... This upright freezer uses ultra-thin vacuum ... traditional urethane insulation, to increase storage ... Holds (336) 2" boxes or 3,336 ... preservation, reduces energy consumption and extends ...
... Simple, economical, moderate-sized CO2 incubator with ... with glass inner door, HEPA filtered ... minimize sample exposure. Simple, large character ... IR CO2 sensing and mulitple temperature ...
... By combining the corrosion resistance ... antibacterial properties of copper, SANYO offers ... sterile, long-lasting and maintenance-free. The sterile ... valid test results and the safety ...
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
Medicine Products: